Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LG AI Research has developed advanced proprietary large language models (“EXAONE”) with multimodal capabilities. Its Bio Intelligence Lab collaborates with leading academic institutions to develop next-generation protein structure prediction tools aimed at accelerating early-stage drug discovery—especially targeting complex multistate proteins implicated in diseases such as Alzheimer’s. The group also works on predictive analytics for cancer diagnosis/treatment. No direct clinical trial results reported; impact measured by enabling partner pipelines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LG AI Research.